Clinical trials for influenza in United States

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

Study ID: NCT06191393

Sponsor

Aptitude Medical Systems

Xofluza-Wearables Feasibility-Study

Study ID: NCT06161454

Sponsor

Children's Hospital of Philadelphia

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

Study ID: NCT06821061

Sponsor

BioNTech SE

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Study ID: NCT06382311

Sponsor

GlaxoSmithKline

COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System

Study ID: NCT06160128

Sponsor

VA Office of Research and Development

Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older

Study ID: NCT06907511

Sponsor

Sanofi

Response to Influenza Vaccination in Pediatric Oncology Patients

Study ID: NCT05384288

Sponsor

St. Jude Children's Research Hospital

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

Study ID: NCT06029933

Sponsor

Kaiser Permanente

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Study ID: NCT06863142

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

Study ID: NCT05040659

Sponsor

Massachusetts General Hospital